Dose-dependent induction of carcinomas and glutathione S-transferase placental form negative eosinophilic foci in the rat liver by di(2- ethylhexyl)phthalate after diethylnitrosamine initiation

Journal of Toxicological Sciences

Volumn 24, Issue 3, 1999, Pages 177-186

  Sano, Masashi ^a,c   Hagiwara, Akihiro ^c   Tamano, Seiko ^c   Hasegawa, Ryohei ^a   Imaida, Katsumi ^a   Ito, Nobuyuki ^b   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c Daiyukai Research Institute for Medical Science   (Japan)

Author keywords

Altered hepatic foci; DEHP; Dose response study; GST P positive and negative foci; Hepatocarcinogenesis; Peroxisome proliferator; Rat

Indexed keywords

CLOFIBRATE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; DIET THERAPY; DOSE RESPONSE; FEEDING; LIVER CANCER; LIVER HYPERTROPHY; LIVER RESECTION; MUTAGENESIS; NONHUMAN; PEROXISOME; RAT;

ANIMALIA;

EID: 0032836364     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.24.3_177     Document Type: Article

References (43)

1. Ashby, J., Brady, A., Elcombe, C. R., Elliot, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S. and Purchase, I. F. H. (1994): Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol., 13, Suppl. 2, S1-S117.
2. Bannasch, P. (1986): Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic neoplasia. Carcinogcnesis, 7, 689-695.
3. Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D. and Wiegand, H.-J. (1993): Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol., 31, 857-907.
4. Butter-worth, B. E., Bermudez, E., Smith-Oliver, T., Earle, L., Cattley, R., Martin, J., Popp, J. A., Strom, S., Jirtle, R. and Michalopous, G. (1984): Lack of genotoxic activity of di(2-ethlyhexyl)phthalate (DEHP) in rat and human hepatocyte. Carcinogenesis, 5, 1329-1335.
5. Cattley, R. C., Kato, M., Popp, J. A., Teets, V. J. and Voss, K. S. (1994): Initiator-specific promotion of hepatocarcinogenesis by WY-14, 643 and clofibrate. Carcinogenesis, 15, 1763-1766.
6. Cattley, R. C. and Preston, R. J. (1995): Does DNA damage play a role in rodent liver cancer induced by peroxisome proliferators? CIIT Activities, 15, 1-6.
7. Chen, Z.-Y., Liu, Y.-F., He, C.-Y., White, C. C. and Eaton, D. L. (1994): Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules. Cancer Res., 54, 2622-2629.
8. Deangelo, A. B. and Garrett, C. T. (1983): Inhibition of development of preneoplastic lesions in the livers of rats fed a weakly carcinogenic environmental contaminant. Cancer Lett., 20, 199-205.
9. Gerbracht, U., Bursch, W., Kraus, P., Putz, B., Reinacher, M., Timmermann-Trosiener, I. and Schulte-Hermann, R. (1990): Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis, 11, 617-624.
10. Gerbracht, U., Einig, C., Oesterle, D., Deml, E., Schlatterer, B. and Eigenbrodt, E. (1990): Di(2-ethylhexyl)phthalate alters carbohydrate enzyme activities and foci incidence in rat liver. Carcinogenesis, 11, 2111-2115.
11. Glauert, H. P., Beer, D., Rao, M. S., Schwarz, M., Xu, Y.-D., Goldsworthy, T. L., Coloma, J. and Pitot, H. C. (1986): Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer, Res., 46, 4601-4606.
12. Goodman, D. G., Maronpot, R. R., Newberne, P. M., Popp, J. A. and Squire, R. A. (1994): Proliferative and selected other lesions in the liver of rats, GI-5. In Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC.
13. Grasl-Kraupp, B., Huber, W., Putz, B., Gerbracht, U. and Schulte-Hermann, R. (1990): Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in the rat liver. Cancer Res., 50, 3701-3708.
14. Grasl-Kraupp, B., Huber, W., Timmermann-Trosiener, I. and Schulte-Hermann, R. (1993): Peroxisome enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin. Carcinogenesis, 14, 2435-2437.
15. Grasl-Kraupp, B., Waldhör, T., Huber, W. and Schulte-Hermann, R. (1993): Glutathione S-transferase isoenzyme patterns in different subtypes of enzymealtered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis, 14, 2407-2412.
16. Greaves, P., Irisarri, E. and Monro, A. M. (1986): Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility. J. Natl. Cancer Inst., 76, 475-484.
17. Harada, T., Maronpot, R. R., Morris, R. W., Stitzel, K. A. and Boorman, G. A. (1989): Morphological and steological characterization of hepatic foci of cellular alteration in control Fischer 344 rats. Toxicol. Pathol., 17, 579-593.
18. Hasegawa, R. and Ito, N. (1992): Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. Food Chem. Toxicol., 11, 979-992.
19. Hasegawa, R., Yoshida, T., Mizoguchi, Y., Futakuchi, M., Kim, D. J., Cui, L. and Ito, N. (1994): Phenotypic alteration of hepatocellular foci in rats treated with clofibrate and phenobarbital. Cancer Lett., 83, 89-95.
20. Hosokawa, S., Tatematsu, M., Aoki, T., Nakanowatari, J., Igarashi, T. and Ito, N. (1989): Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator. Carcinogenesis, 10, 2237-2241.
21. Ito, N., Hasegawa, R., Imaida, K., Hirose, M., Shirai, T., Tamano, S. and Hagiwara, A. (1997): Medium-term rat liver bioassay for rapid detection of hepatocarcinogenic substances. J. Toxicol. Pathol., 10, 1-11.
22. Ito, N., Hasegawa, R., Imaida, K., Masui, T., Takahashi, S. and Shirai, T. (1992): Pathological markers for non-genotoxic agent-associated carcinogenesis. Toxicol Lett, 64/65, 613-620.
23. Ito, N., Tsuda, H., Tatematsu, M., Inoue, T., Tagawa, Y., Aoki, T., Uwagawa, S., Kagawa, M., Ogiso, T., Masui, T., Imaida, K., Fukushima, S. and Asamoto, M. (1988): Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis, 9, 387-394.
24. Kasai, H., Okada, Y., Nishimura, S., Rao, M. S. and Reddy, J. K. (1989): Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49, 2603-2605.
25. Kluwe, W. M., Haseman, J. K., Douglas, J. F. and Huff, J. E. (1982): The carcinogenicity of dietary di(2-ethylhexyl)phthalate (DEHP) in Fisher 344 rats and B6C3F1 mice. J. Toxicol. Environ. Health, 10, 797-815.
26. Lake, B. G., Kozlen, S. L., Evans, J. G., Tim, J. B. G., Philip, J. Y. and Gangolli, S. D. (1987): Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology, 44, 213-228.
27. Marsman, D. S., Cattley, R. C., Conway, J. G. and Popp, J. A. (1988): Relationship of hepatic peroxisome proliferation and rcplicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2, 3-xylidino)-2-primidinylthio]acetic acid (Wy-14, 643) in rats. Cancer Res., 48, 6739-6744.
28. Miller, R. T., Glover, S. E., Stewart, W. S., Corton, J. C., Popp, J. A. and Cattley, R. C. (1996): Effect of the expression of c-met, c-mic and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14, 643. Carcinogenesis, 17, 1337-1341.
29. Moody, D. E., Reddy, J. K., Lake, B. G., Popp, J. A. and Reese, D. H. (1991): Peroxisome proliferation and nongenotoxic Carcinogenesis: Commentary on a symposium. Fund. Appl. Toxicol., 16, 233-248.
30. Oesterle, D. and Deml, E. (1988): Promoting activity of di(2-ethylhexyl)phthalate in rat liver foci bioassay. J. Cancer Res. Clin. Oncol., 114, 133-136.
31. Popp, J. A., Garvey, L. K., Hamm, T. E. J. and Swenberg, J. A. (1985): Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate. Carcinogenesis, 6, 141-144.
32. Rao, M. S., Nemali, M. R., Usuda, N., Scarpelli, D. G., Makino, T., Pitot, H. C. and Reddy, J. K. (1988): Lack of expression of glutathione S-transferase P, γ-glutamyl transpeptidase, and α-fetoprotein messenger RNAs in liver tumor induced by peroxisome proliferators. Cancer Res., 48, 4919-4925.
33. Rao, M. S. and Reddy, J. K. (1987): Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis, 8, 631-636.
34. Rao, M. S., Tatematsu, M., Subbarao, V., Ito, N. and Reddy, J. K. (1986): Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and γ-glutamyltranspeptidase. Cancer Res., 46, 5287-5290.
35. Rao, M. S., Usuda, N., Subbarao, V. and Reddy, J. K. (1987): Absence of γ-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalale, a peroxisome proliferator. Carcinogenesis, 8, 1347-1350.
36. Schmerzer, P., Pool, B. L., Klein, R. G., Komitowski, D. and Schmähl, D. (1988): Various short-term assays and two long-term studies with the plasticizer di(2-ethylhexyl)phthalate in the Syrian golden hamster. Carcinogenesis, 9, 37-43.
37. Shirai, T. (1997): A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: a historical review of model development and summary of results from 291 tests. Toxicol. Pathol., 25, 453-460.
38. Takagi, A., Sai, K., Umemura, T., Hasegawa, R. and Kurokawa, Y. (1990): Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats folowing short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer Res., 81, 213-215.
39. Tatematsu, M., Mera, Y., Ito, N., Satoh, K. and Sato, K. (1985): Relative merits of immunohistochemical demonstration of placental A, B and C forms of glutathione S-transferase and histochemical demonstration of γ-glutatione transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis, 6, 1621-1626.
40. Tsuda, H., Asamoto, M., Iwahori, Y., Hori, T., Ota, T., Baba-Toriyama, H., Uehara, N., Kim, D. J., Krutovskikh, V. A., Takasuka, N., Tsuchiya, T., Mutai. M., Tatematsu, M. and Yamasaki, H. (1996): Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplasitic lesions not shared with spontaneously occurring lesions in the rat liver. Carcinogenesis, 17, 2441-2448.
41. Williams, G. M., Maruyama, H. and Tanaka, T. (1987): Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver Carcinogenesis. Carcinogenesis, 8, 875-880.
42. Yeldandi, A. V., Subbarao, V., Rajan, A. and Rao, M. S. (1989): γ-glutamyltranspeptidase-negative phenotypic property of preneoplastic and neoplastic liver lesions induced by ciprofibrate does not change following 2-acethylaminofluorene. Carcinogenesis, 10, 797-799.
43. Yoshimura, I. (1987): Statistical analysis of toxicity and drug efficacy data. 28-40.